98 related articles for article (PubMed ID: 33796492)
1. Promoting Aspirin Use for Cardiovascular Disease Prevention Among an Adult Internet-Using Population: A Pilot Study.
Oldenburg NC; Horvath KJ; Van't Hof J; Misialek JR; Hirsch AT
Front Public Health; 2021; 9():500296. PubMed ID: 33796492
[TBL] [Abstract][Full Text] [Related]
2. Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial.
Luepker RV; Eder M; Finnegan JR; Van't Hof JR; Oldenburg N; Duval S
JAMA Netw Open; 2022 May; 5(5):e2211107. PubMed ID: 35536579
[TBL] [Abstract][Full Text] [Related]
3. Use of aspirin for prevention of cardiovascular disease--1981-82 to 1985-86: the Minnesota Heart Survey.
Folsom AR; Iso H; Sprafka JM; Edlavitch SA; Luepker RV
Am Heart J; 1988 Sep; 116(3):827-30. PubMed ID: 3261930
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of QuitNow Men: An Online, Men-Centered Smoking Cessation Intervention.
Bottorff JL; Oliffe JL; Sarbit G; Sharp P; Caperchione CM; Currie LM; Schmid J; Mackay MH; Stolp S
J Med Internet Res; 2016 Apr; 18(4):e83. PubMed ID: 27097991
[TBL] [Abstract][Full Text] [Related]
5. Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Asia-Pacific.
Zaninelli A; Hu DY; Kaufholz C; Schwappach D
Postgrad Med; 2010 Jan; 122(1):108-17. PubMed ID: 20107294
[TBL] [Abstract][Full Text] [Related]
6. Aspirin use among adults aged 40 and older in the United States: results of a national survey.
Pignone M; Anderson GK; Binns K; Tilson HH; Weisman SM
Am J Prev Med; 2007 May; 32(5):403-407. PubMed ID: 17478266
[TBL] [Abstract][Full Text] [Related]
7. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study.
Van't Hof JR; Duval S; Walts A; Kopecky SL; Luepker RV; Hirsch AT
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974502
[TBL] [Abstract][Full Text] [Related]
8. The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly).
Silagy CA; McNeil JJ; Donnan GA; Tonkin AM; Worsam B; Campion K
J Am Geriatr Soc; 1994 Jun; 42(6):643-7. PubMed ID: 8201151
[TBL] [Abstract][Full Text] [Related]
9. A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.
Oldenburg NC; Duval S; Luepker RV; Finnegan JR; LaMarre H; Peterson KA; Zantek ND; Jacobs G; Straka RJ; Miller KH; Hirsch AT
Prev Chronic Dis; 2014 May; 11():E83. PubMed ID: 24831287
[TBL] [Abstract][Full Text] [Related]
10. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
11. Can the COPD web be used to promote self-management in patients with COPD in swedish primary care: a controlled pragmatic pilot trial with 3 month- and 12 month follow-up.
Nyberg A; Tistad M; Wadell K
Scand J Prim Health Care; 2019 Mar; 37(1):69-82. PubMed ID: 30700230
[TBL] [Abstract][Full Text] [Related]
12. A Preliminary Exploration of Former Smokers Enrolled in an Internet Smoking Cessation Program.
Cha S; Cohn AM; Elmasry H; Graham AL
JMIR Res Protoc; 2016 Jun; 5(2):e119. PubMed ID: 27302500
[TBL] [Abstract][Full Text] [Related]
13. Why are people downloading the freeware AIDA diabetes computing software program: a pilot study.
Lehmann ED
Diabetes Technol Ther; 2002; 4(6):793-808. PubMed ID: 12685803
[TBL] [Abstract][Full Text] [Related]
14. A community-based group randomized trial to increase aspirin use for primary prevention of cardiovascular disease: Study protocol and baseline results for the "Ask About Aspirin" initiative.
Duval S; Van't Hof JR; Oldenburg NC; Eder M; Finnegan JR; Luepker RV
Contemp Clin Trials Commun; 2021 Jun; 22():100772. PubMed ID: 34027223
[TBL] [Abstract][Full Text] [Related]
15. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T; Miller T; Ko S
Ann Intern Med; 2009 Mar; 150(6):405-10. PubMed ID: 19293073
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
J Cardiovasc Risk; 1995 Apr; 2(2):137-42. PubMed ID: 7606650
[TBL] [Abstract][Full Text] [Related]
17. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women.
Rivera CM; Song J; Copeland L; Buirge C; Ory M; McNeal CJ
J Womens Health (Larchmt); 2012 Apr; 21(4):379-87. PubMed ID: 22303820
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
Nelson MR; Reid CM; Ames DA; Beilin LJ; Donnan GA; Gibbs P; Johnston CI; Krum H; Storey E; Tonkin A; Wolfe R; Woods R; McNeil JJ
Med J Aust; 2008 Jul; 189(2):105-9. PubMed ID: 18637782
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of visitors and revisitors to an Internet-delivered computer-tailored lifestyle intervention implemented for use by the general public.
Brouwer W; Oenema A; Raat H; Crutzen R; de Nooijer J; de Vries NK; Brug J
Health Educ Res; 2010 Aug; 25(4):585-95. PubMed ID: 19897515
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention studies and the healthy elderly: evaluating barriers to recruitment.
Boles M; Getchell WS; Feldman G; McBride R; Hart RG
J Community Health; 2000 Aug; 25(4):279-92. PubMed ID: 10941692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
